|
COPYRIGHT 2004 International Medical News Group
BARCELONA, SPAIN -- Tacrolimus ointment proved superior to mid- to high-potency topical corticosteroids in adults with atopic dermatitis in the first large double-blind clinical trial to compare the topical immune modulator with standard treatment rather than with placebo, Dr. Sakari Reitamo said at the 12th Congress of the European Academy of Dermatology and Venereology.
He reported on 972 adults with moderate to severe atopic dermatitis in a 6-month, 57-center, 12-nation European clinical trial. Patients were randomized to twice-daily 0.1% tacrolimus ointment or 1% hydrocortisone acetate ointment...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
